Is Proximal 16p11.2 Microdeletion Syndrome hereditary?

Proximal 16p11.2 microdeletion syndrome is a genetic condition that is often inherited in an autosomal dominant pattern, though it frequently occurs as a de novo (spontaneous) event. While it is hereditary, the clinical presentation can vary significantly between family members, meaning a parent may have very mild symptoms while their child is more severely affected.

Is Proximal 16p11.2 microdeletion syndrome hereditary?

Yes, Proximal 16p11.2 microdeletion syndrome is a genetic condition caused by the loss of a small segment of genetic material on chromosome 16. It follows an autosomal dominant inheritance pattern, which means an affected individual has a 50% chance of passing the deletion to each of their children. However, many cases of Proximal 16p11.2 microdeletion syndrome are not inherited from a parent but arise as a de novo mutation during the formation of reproductive cells or early embryonic development.

How is this condition diagnosed?

Diagnosis is confirmed through specialized genetic testing, typically a chromosomal microarray (CMA). Because the symptoms of Proximal 16p11.2 microdeletion syndrome—such as developmental delay, speech difficulties, or autism spectrum disorder—can overlap with other conditions, clinical geneticists recommend testing for children presenting with unexplained neurodevelopmental challenges. Genetic testing is also recommended for parents of an affected child to determine if the deletion was inherited or occurred spontaneously.

What are the implications for family planning?

Genetic counseling is essential for families navigating a diagnosis of Proximal 16p11.2 microdeletion syndrome. Counselors provide clarity on recurrence risks and discuss reproductive options. Key considerations include:

• Parental Testing: Parents should undergo microarray testing to check for the deletion, even if they show no obvious symptoms.


• Recurrence Risk: If a parent carries the deletion, there is a 50% risk for each subsequent pregnancy.


• Prenatal Options: Families may explore prenatal diagnostic testing (such as CVS or amniocentesis) or preimplantation genetic testing (PGT) if they are known carriers.


• Variable Expressivity: It is important to remember that individuals with Proximal 16p11.2 microdeletion syndrome may have vastly different health and cognitive outcomes, even within the same family.

Our DiseaseMaps.org community currently includes 8 members who have shared their experiences with Proximal 16p11.2 microdeletion syndrome, providing a unique space for peer support.

Next steps

• Consult with a board-certified clinical geneticist to review microarray results and inheritance patterns.


• Connect with the DiseaseMaps.org community to share experiences with other families affected by Proximal 16p11.2 microdeletion syndrome.


• Request a referral to a genetic counselor to discuss family planning and prenatal diagnostic options.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): 16p11.2 deletion syndrome.


• Orphanet: 16p11.2 microdeletion syndrome.


• OMIM (Online Mendelian Inheritance in Man): Chromosome 16p11.2 deletion syndrome.


• Simons Searchlight: Research and clinical data on 16p11.2 deletions.